Articles with "dose anti" as a keyword



Photo by finnnyc from unsplash

AB1035 Ultra-low dose anti-interleukin1 in chronic gout: a safe and successful combination therapy with low dose colchicine and urate lowering agents

Sign Up to like & get
recommendations!
Published in 2018 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2018-eular.7590

Abstract: Background Gout is the most common inflammatory arthritis in humans; is caused by deposition of monosodium urate (MSU) crystals within and around joints. Left untreated, a more chronic course may develop, characterised by persistent inflammation… read more here.

Keywords: low dose; dose anti; therapy; gout ... See more keywords
Photo by towfiqu999999 from unsplash

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

Sign Up to like & get
recommendations!
Published in 2018 at "Diabetes Care"

DOI: 10.2337/dc18-0494

Abstract: OBJECTIVE A pilot study suggested that combination therapy with low-dose anti-thymocyte globulin (ATG) and pegylated granulocyte colony-stimulating factor (GCSF) preserves C-peptide in established type 1 diabetes (T1D) (duration 4 months to 2 years). We hypothesized… read more here.

Keywords: low dose; dose atg; dose anti; atg ... See more keywords
Photo from wikipedia

Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer’s Disease

Sign Up to like & get
recommendations!
Published in 2022 at "Frontiers in Pharmacology"

DOI: 10.3389/fphar.2022.902254

Abstract: A small dose of the anti-HIV drug efavirenz (EFV) was previously discovered to activate CYP46A1, a cholesterol-eliminating enzyme in the brain, and mitigate some of the manifestation of Alzheimer’s disease in 5XFAD mice. Herein, we… read more here.

Keywords: alzheimer disease; dose anti; retinal vascular; vascular lesions ... See more keywords
Photo from wikipedia

No effect of norepinephrine dose on anti-Xa activity in critically ill patients
.

Sign Up to like & get
recommendations!
Published in 2020 at "International journal of clinical pharmacology and therapeutics"

DOI: 10.5414/cp203640

Abstract: OBJECTIVE Low-molecular-weight heparins are frequently used to prevent venous thromboembolism. Vasopressor therapy may be associated with inadequate anti-factor Xa activity, thereby increasing the risk of venous thromboembolism. We aimed to assess the association between anti-factor… read more here.

Keywords: activity; norepinephrine dose; factor; dose anti ... See more keywords